InvestorsHub Logo
Followers 44
Posts 10455
Boards Moderated 0
Alias Born 01/13/2016

Re: None

Tuesday, 11/29/2022 4:49:17 AM

Tuesday, November 29, 2022 4:49:17 AM

Post# of 462658
94%is around 480 Patients enrolled in the OLE.

Wouldn’t there be some sort of moral obligation to discontinue treatment if there is no benefit?

Would not you have to announce bad TLD immediately?

So the battle of wills is the Data is good enough to continue OLE and do CTAD/Peer Reviewed but not good enough without another Phase 3..

Biogen is killing people and their stock didn’t drop as much as ours?

The hiring of employees
The excitement at CTAD
Bringing in Dr Mac to make presentation
Saying Peer Reviewed

It doesn’t make sense if you do not meet
your endpoints..
if you have met your endpoints and you know the short bastards are out there..

You should respond to their attack and not be a damned turtle ..

I am and have been disappointed by out
Battle strategy.. too many casualties for winning every damned science battle.

At some point TGD should have engaged the elephant in the room..
Big Pharma hates us..
Would have liked to seen AF attacked legally yesterday
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News